A cis‐eQTL genetic variant in PLK4 confers high risk of hepatocellular carcinoma

The overexpression and knockdown of PLK4 were both reported to generate aneuploidy. Thus, we aimed to investigate whether genetic variants in PLK4 contribute to the development of hepatocellular carcinoma (HCC).

[1]  J. Tkach,et al.  Atypical function of a centrosomal module in WNT signalling drives contextual cancer cell motility , 2019, Nature Communications.

[2]  G. Nolan,et al.  Role for polo-like kinase 4 in mediation of cytokinesis , 2019, Proceedings of the National Academy of Sciences.

[3]  David R. Piper,et al.  Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer , 2019, International journal of molecular sciences.

[4]  Zhibin Hu,et al.  Gene amplification derived a cancer‐testis long noncoding RNA PCAT6 regulates cell proliferation and migration in hepatocellular carcinoma , 2019, Cancer medicine.

[5]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[6]  J. Llovet,et al.  Molecular therapies and precision medicine for hepatocellular carcinoma , 2018, Nature Reviews Clinical Oncology.

[7]  P. M. P. van Bergen en Henegouwen,et al.  MAGE-A antigens as targets for cancer immunotherapy. , 2018, Cancer treatment reviews.

[8]  J. Long,et al.  A Comprehensive cis-eQTL Analysis Revealed Target Genes in Breast Cancer Susceptibility Loci Identified in Genome-wide Association Studies. , 2018, American journal of human genetics.

[9]  André F. Vieira,et al.  Over-elongation of centrioles in cancer promotes centriole amplification and chromosome missegregation , 2018, Nature Communications.

[10]  G. Ying,et al.  Polo-like kinase 4 mediates epithelial–mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway , 2018, Cell Death & Disease.

[11]  M. Burkard,et al.  Centriole Overduplication is the Predominant Mechanism Leading to Centrosome Amplification in Melanoma , 2018, Molecular Cancer Research.

[12]  Hongbing Shen,et al.  Genome-Wide Association Study Identifies a New Locus at 7q21.13 Associated with Hepatitis B Virus–Related Hepatocellular Carcinoma , 2017, Clinical Cancer Research.

[13]  Sarah E. Seton-Rogers.  Tumorigenesis: Fitness penalties of aneuploidy , 2017, Nature Reviews Cancer.

[14]  D. Lambrechts,et al.  Centrosome Amplification Is Sufficient to Promote Spontaneous Tumorigenesis in Mammals. , 2017, Developmental cell.

[15]  John T. Powers,et al.  The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma , 2016, Leukemia.

[16]  G. C. Rogers,et al.  A centrosome interactome provides insight into organelle assembly and reveals a non-duplication role for Plk4 , 2016, Nature Communications.

[17]  T. Toda,et al.  A non‐canonical function of Plk4 in centriolar satellite integrity and ciliogenesis through PCM1 phosphorylation , 2016, EMBO reports.

[18]  J. Prieto,et al.  Immunological landscape and immunotherapy of hepatocellular carcinoma , 2015, Nature Reviews Gastroenterology &Hepatology.

[19]  D. Lambrechts,et al.  Transient PLK4 overexpression accelerates tumorigenesis in p53-deficient epidermis , 2015, Nature Cell Biology.

[20]  T. Mak,et al.  Targeting Mitosis in Cancer: Emerging Strategies. , 2015, Molecular cell.

[21]  G. C. Rogers,et al.  Autoinhibition and relief mechanism for Polo-like kinase 4 , 2015, Proceedings of the National Academy of Sciences.

[22]  Sihem Zitouni,et al.  Polo-like kinases: structural variations lead to multiple functions , 2014, Nature Reviews Molecular Cell Biology.

[23]  Y. Pan,et al.  CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis , 2014, Cell Death and Disease.

[24]  K. Polyak,et al.  Oncogene-like induction of cellular invasion from centrosome amplification , 2014, Nature.

[25]  Angelique W Whitehurst,et al.  Cause and consequence of cancer/testis antigen activation in cancer. , 2014, Annual review of pharmacology and toxicology.

[26]  Joseph K. Pickrell.  Joint analysis of functional genomic data and genome-wide association studies of 18 human traits , 2013, bioRxiv.

[27]  H. Saito,et al.  SAPK pathways and p53 cooperatively regulate PLK4 activity and centrosome integrity under stress , 2013, Nature Communications.

[28]  A. McKenna,et al.  Integrative eQTL-Based Analyses Reveal the Biology of Breast Cancer Risk Loci , 2013, Cell.

[29]  D. Meek,et al.  MAGE-A antigens as targets in tumour therapy. , 2012, Cancer letters.

[30]  H. El‐Serag,et al.  Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.

[31]  Hongbing Shen,et al.  Genetic variants in human leukocyte antigen/DP‐DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development , 2012, Hepatology.

[32]  M. Maio,et al.  The biology of cancer testis antigens: Putative function, regulation and therapeutic potential , 2011, Molecular oncology.

[33]  M. Malumbres,et al.  Plk5, a Polo Box Domain-Only Protein with Specific Roles in Neuron Differentiation and Glioblastoma Suppression , 2011, Molecular and Cellular Biology.

[34]  K. Strebhardt,et al.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy , 2010, Nature Reviews Drug Discovery.

[35]  J. Dennis,et al.  Plk4 is required for cytokinesis and maintenance of chromosomal stability , 2010, Proceedings of the National Academy of Sciences.

[36]  Yan Liu,et al.  Global Burden of Aflatoxin-Induced Hepatocellular Carcinoma: A Risk Assessment , 2010, Environmental health perspectives.

[37]  K. Lange,et al.  Prioritizing GWAS results: A review of statistical methods and recommendations for their application. , 2010, American journal of human genetics.

[38]  D. Cleveland,et al.  Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis , 2009, Nature Reviews Molecular Cell Biology.

[39]  David Pellman,et al.  A Mechanism Linking Extra Centrosomes to Chromosomal Instability , 2009, Nature.

[40]  F. Bertucci,et al.  Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis. , 2008, Cancer research.

[41]  L. Lehmann,et al.  SAK/PLK4 Is Required for Centriole Duplication and Flagella Development , 2005, Current Biology.

[42]  K. Fukasawa,et al.  Centrosome amplification, chromosome instability and cancer development. , 2005, Cancer letters.

[43]  Christopher J. Wilkinson,et al.  The Polo kinase Plk4 functions in centriole duplication , 2005, Nature Cell Biology.

[44]  Lloyd J. Old,et al.  Cancer/testis antigens, gametogenesis and cancer , 2005, Nature Reviews Cancer.

[45]  J. Dennis,et al.  Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis , 2005, Nature Genetics.

[46]  J. Dennis,et al.  Sak/Plk4 and mitotic fidelity , 2005, Oncogene.

[47]  G. Gores,et al.  Hepatocellular carcinoma , 2016, Nature Reviews Disease Primers.